Core Alternative Capital’s Novartis NVS Stock Holding History

Core Alternative Capital's NVS Position: Q2 2023 in Review

Core Alternative Capital sold out of Novartis (NVS) in Q2 2023, closing a stake of 20 shares — an estimated $1.84K sold.

Core Alternative Capital first reported a position in NVS in Q4 2021 and held it in 4 quarters. The position peaked at $14.1K in Q4 2022. 1,202 funds tracked by Wall St. Rank hold NVS as of Q2 2023.

• Core Alternative Capital reported no remaining Novartis position as of Q2 2023 after selling out during the quarter.
• Core Alternative Capital sold 20 Novartis shares in Q2 2023, an estimated $1.84K.
• Core Alternative Capital first reported a position in Novartis in Q4 2021 and held it in 4 quarters.
• Core Alternative Capital's Novartis position peaked at $14.1K in Q4 2022.
• 1,202 funds tracked by Wall St. Rank held Novartis as of Q2 2023.

Based on Core Alternative Capital's 13F filing for Q2 2023, filed 27 Jul 2023.